Craft

Avid Bioservices

Stock Price

$6.7

2024-03-22

Market Capitalization

$425.6 M

2024-03-22

Revenue

$149.3 M

FY, 2023

Avid Bioservices Summary

Company Summary

Overview
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company, which is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products through its contract manufacturing business and through licensing its development-stage immunotherapy products. Avid provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Type
Public
Status
Active
Founded
1981
HQ
Tustin, CA, US | view all locations
Website
https://avidbio.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Joseph Carleone, Chairman of the Board

    • Daniel Hart

      Daniel Hart, Chief Financial Officer

      • Richard B. Hancock, Interim President and CEO

        • Mark Ziebell

          Mark Ziebell, VP General Counsel & Corporate Secretary

          Operating MetricsView all

          Phase I/II Trials Products

          1

          FY, 2016

          LocationsView all

          1 location detected

          • Tustin, CA HQ

            United States

            2642 Michelle Dr #200

          Avid Bioservices Financials

          Summary Financials

          Revenue (Q2, 2024)
          $25.4M
          Gross profit (Q2, 2024)
          ($4.7M)
          Net income (Q2, 2024)
          ($9.5M)
          Cash (Q2, 2024)
          $31.4M
          EBIT (Q2, 2024)
          ($11.2M)
          Enterprise value
          $451.0M

          Footer menu